Elevance Health, Inc. ELV
Institutional shares held
199 Million
2.52M
calls
2.23M
puts
Total value of holdings
$64.9B
$820M
calls
$725M
puts
Market Cap
$78.2B
240,000,992
Shares Out.
Institutional ownership
82.96%
# of Institutions
1,784
We take great care to ensure that the data presented and summarized in this overview for Elevance Health, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding ELV
View all-
Vanguard Group Inc Valley Forge, PA23MShares$7.49 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY20.7MShares$6.75 Billion0.26% of portfolio
-
State Street Corp Boston, MA10.3MShares$3.37 Billion0.12% of portfolio
-
Wellington Management Group LLP Boston, MA6.62MShares$2.16 Billion0.39% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.84MShares$1.9 Billion0.2% of portfolio
-
Sanders Capital, LLC West Palm Beach, FL5.77MShares$1.88 Billion2.29% of portfolio
-
Geode Capital Management, LLC Boston, MA5.14MShares$1.68 Billion0.11% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.58MShares$1.49 Billion2.26% of portfolio
-
First Eagle Investment Management, LLC4MShares$1.3 Billion2.44% of portfolio
-
Harris Associates L P Chicago, IL3.19MShares$1.04 Billion1.71% of portfolio
Latest Institutional Activity in ELV
Top Purchases
Top Sells
About ELV
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Insider Transactions at ELV
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 02
2025
|
Mark Kaye EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,895
-15.26%
|
$984,300
$340.24 P/Share
|
|
Sep 03
2025
|
Erin M Wessling EVP & Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
152
-2.94%
|
$48,792
$321.59 P/Share
|
|
Sep 02
2025
|
Ryan R Craig EVP & Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
970
+15.34%
|
-
|
|
Sep 02
2025
|
Erin M Wessling EVP & Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
931
+15.25%
|
-
|
|
Aug 19
2025
|
Susan D. De Vore Director |
BUY
Open market or private purchase
|
Direct |
1,200
+25.52%
|
$374,400
$312.15 P/Share
|
|
Aug 01
2025
|
Steven H Collis Director |
BUY
Grant, award, or other acquisition
|
Direct |
639
+50.0%
|
-
|
|
Jul 18
2025
|
Gail Boudreaux President and CEO |
BUY
Open market or private purchase
|
Direct |
8,500
+1.86%
|
$2,439,500
$287.05 P/Share
|
|
May 14
2025
|
Susan D. De Vore Director |
BUY
Grant, award, or other acquisition
|
Direct |
601
+20.7%
|
-
|
|
May 14
2025
|
Robert L Dixon Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
601
+5.5%
|
-
|
|
May 14
2025
|
Lewis Hay Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
601
+4.96%
|
-
|
|
May 14
2025
|
Bahija Jallal Director |
BUY
Grant, award, or other acquisition
|
Direct |
601
+11.15%
|
-
|
|
May 14
2025
|
Antonio F Neri Director |
BUY
Grant, award, or other acquisition
|
Direct |
601
+10.88%
|
-
|
|
May 14
2025
|
Ramiro G Peru Director |
BUY
Grant, award, or other acquisition
|
Direct |
601
+6.04%
|
-
|
|
May 14
2025
|
Ryan M. Schneider Director |
BUY
Grant, award, or other acquisition
|
Direct |
601
+8.35%
|
-
|
|
May 14
2025
|
Deanna D Strable Soethout Director |
BUY
Grant, award, or other acquisition
|
Direct |
601
+26.75%
|
-
|
|
May 14
2025
|
R Kerry Clark Director |
BUY
Grant, award, or other acquisition
|
Direct |
601
+5.87%
|
-
|
|
Apr 24
2025
|
Mark Kaye EVP & CFO |
SELL
Open market or private sale
|
Direct |
4,588
-19.47%
|
$1,945,312
$424.82 P/Share
|
|
Mar 10
2025
|
Ronald W Penczek CAO & Controller |
SELL
Open market or private sale
|
Direct |
443
-19.35%
|
$183,845
$415.13 P/Share
|
|
Mar 05
2025
|
Charles Morgan Kendrick Jr EVP & President, Commercial |
SELL
Open market or private sale
|
Direct |
3,504
-25.73%
|
$1,387,584
$396.3 P/Share
|
|
Mar 03
2025
|
Charles Morgan Kendrick Jr EVP & President, Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
6,531
+21.78%
|
-
|
Last 12 Months Summary
Buy / Acquisition
71.5K
Shares
From
21
Insiders
| Grant, award, or other acquisition | 61.8K shares |
|---|---|
| Open market or private purchase | 9.7K shares |
Sell / Disposition
30.3K
Shares
From
12
Insiders
| Payment of exercise price or tax liability | 21.7K shares |
|---|---|
| Open market or private sale | 8.54K shares |